A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2001
12/04/2001	US6326371 Pyrudyl and pyrimidylpiperazine derivatives
12/04/2001	US6326370 Use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity
12/04/2001	US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/04/2001	US6326355 Method for the prevention and treatment of cachexia and anorexia
12/04/2001	US6326353 123therapy for septic shock; administering polymyxin by injection
12/04/2001	US6326352 Compounds and methods for modulating cell adhesion
12/04/2001	US6326199 Hybridization and rnace activation in a cell with oligonucleotides
12/04/2001	US6326179 Enzymatic immunoglobulin; for use as therapeutic and diagnostic tools in treatment of arthritis, viral disease and alzheimer's disease
12/04/2001	US6326169 Nucleotide sequences coding insecticidal protein for use in biological pest control
12/04/2001	US6326001 Recombinant vaccine for diseases caused by encapsulated organisms
12/04/2001	CA2235565C Process for the preparation of rhus verniciflua extract and anti-cancer composition containing same
12/04/2001	CA2229814C Peripherally active anti-hyperalgesic opiates
12/04/2001	CA2139948C Targeting somatic gene therapy to joints
12/04/2001	CA2124763C Lipase inhibitor derived from a defatted rice germ
12/01/2001	CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090421A2 Method of detecting inflammatory lung disorders
11/29/2001	WO2001090404A1 Drug screening systems and assays
11/29/2001	WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090345A2 Methods and compositions for enhancing the delivery of a nucleic acid to a cell
11/29/2001	WO2001090341A1 Antisense modulation of pten expression
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001	WO2001090195A1 Immunoassay method for x-type phospholipase a¿2?
11/29/2001	WO2001090192A2 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090151A2 Human receptor proteins; related reagents and methods
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090109A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
11/29/2001	WO2001090108A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090099A1 Fatty acid synthase inhibitors
11/29/2001	WO2001090095A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
11/29/2001	WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090067A1 Tyrosine phosphatase inhibitors
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001090057A1 Sulfonamide derivatives
11/29/2001	WO2001090056A1 Sulfonamide derivatives
11/29/2001	WO2001089593A1 Transfection system
11/29/2001	WO2001089586A2 Tc and re carbonyl complexes for pertechnetate and perrhenate
11/29/2001	WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001	WO2001089577A2 Conjugates of aminodrugs comprising an oxime bond
11/29/2001	WO2001089570A2 Combination of growth hormone secretagogues and antidepressants
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	WO2001089566A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
11/29/2001	WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089554A2 Treatment of acute coronary syndrome with glp-1
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089543A2 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
11/29/2001	WO2001089542A2 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
11/29/2001	WO2001089538A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/29/2001	WO2001089531A1 Crystal structures of p- selectin,ep0105895-selectin complexes, and uses thereof
11/29/2001	WO2001089530A2 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator
11/29/2001	WO2001089526A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof
11/29/2001	WO2001089516A1 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
11/29/2001	WO2001089515A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	WO2001089514A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
11/29/2001	WO2001089504A1 Tropolone derivatives and pharmaceutical compositions
11/29/2001	WO2001089502A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	WO2001089500A2 Agents and methods for increasing brain chaperonin levels
11/29/2001	WO2001089467A1 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001089319A2 Tryptophan source from plants and uses therefor
11/29/2001	WO2001089282A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001060810B1 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001044465A3 Therapeutically useful synthetic oligonucleotides
11/29/2001	WO2001042272A3 Eplerenone crystalline form exhibiting enhanced dissolution rate
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001038566A3 Screening method for candidate drugs

1 ... 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 ... 1564